Mohsen Rashidi

2.8k total citations · 1 hit paper
96 papers, 1.9k citations indexed

About

Mohsen Rashidi is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Mohsen Rashidi has authored 96 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Molecular Biology, 33 papers in Cancer Research and 13 papers in Oncology. Recurrent topics in Mohsen Rashidi's work include MicroRNA in disease regulation (22 papers), Cancer-related molecular mechanisms research (22 papers) and Circular RNAs in diseases (18 papers). Mohsen Rashidi is often cited by papers focused on MicroRNA in disease regulation (22 papers), Cancer-related molecular mechanisms research (22 papers) and Circular RNAs in diseases (18 papers). Mohsen Rashidi collaborates with scholars based in Iran, Canada and China. Mohsen Rashidi's co-authors include Mehrdad Hashemi, Afshin Taheriazam, Maliheh Entezari, Shokooh Salimimoghadam, Kiavash Hushmandi, Marjan Ghorbani, Sepideh Mirzaei, Matin Chehelgerdi, Mohammad Chehelgerdi and Noushin Nabavi and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cellular and Molecular Life Sciences and Frontiers in Immunology.

In The Last Decade

Mohsen Rashidi

91 papers receiving 1.8k citations

Hit Papers

Comprehensive review of CRISPR-based gene editing: mechan... 2024 2026 2025 2024 25 50 75 100

Peers

Mohsen Rashidi
Mohsen Rashidi
Citations per year, relative to Mohsen Rashidi Mohsen Rashidi (= 1×) peers Qiwei Jiang

Countries citing papers authored by Mohsen Rashidi

Since Specialization
Citations

This map shows the geographic impact of Mohsen Rashidi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohsen Rashidi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohsen Rashidi more than expected).

Fields of papers citing papers by Mohsen Rashidi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mohsen Rashidi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohsen Rashidi. The network helps show where Mohsen Rashidi may publish in the future.

Co-authorship network of co-authors of Mohsen Rashidi

This figure shows the co-authorship network connecting the top 25 collaborators of Mohsen Rashidi. A scholar is included among the top collaborators of Mohsen Rashidi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mohsen Rashidi. Mohsen Rashidi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chehelgerdi, Mohammad, Matin Chehelgerdi, Esmaeil Mahmoudi, et al.. (2024). Comprehensive review of CRISPR-based gene editing: mechanisms, challenges, and applications in cancer therapy. Molecular Cancer. 23(1). 9–9. 113 indexed citations breakdown →
2.
Eslami, Masoud, Ramin Khorrami, Noushin Nabavi, et al.. (2024). Role of lncRNAs in brain tumors. Gene Reports. 35. 101904–101904. 3 indexed citations
3.
Nabavi, Noushin, et al.. (2024). Mechanistic insights into cisplatin response in breast tumors: Molecular determinants and drug/nanotechnology-based therapeutic opportunities. Mutation Research/Reviews in Mutation Research. 794. 108513–108513. 5 indexed citations
4.
Koohpar, Zeinab Khazaei, Ali Moghadas Jafari, Shokooh Salimimoghadam, et al.. (2024). Highlighting function of Wnt signalling in urological cancers: Molecular interactions, therapeutic strategies, and (nano)strategies. Translational Oncology. 50. 102145–102145. 1 indexed citations
5.
Hashemi, Mehrdad, Fatemeh Habibi, Ramin Khorrami, et al.. (2024). Emerging roles of non-coding RNAs in modulating the PI3K/Akt pathway in cancer. Non-coding RNA Research. 10. 1–15. 8 indexed citations
6.
Rashidi, Mohsen, et al.. (2024). The neuropharmacological and clinical effects of lutein: a systematic review. Hormone Molecular Biology and Clinical Investigation. 46(1). 27–38. 1 indexed citations
7.
Rezaee, Aryan, Romina Rajabi, Ramin Khorrami, et al.. (2023). PI3K/Akt signaling in urological cancers: Tumorigenesis function, therapeutic potential, and therapy response regulation. European Journal of Pharmacology. 955. 175909–175909. 13 indexed citations
8.
Pouramiri, Behjat & Mohsen Rashidi. (2023). Microwave-promoted multi-component and green synthesis of thiadiazolo[3,2-a]pyrimidines under solvent-free conditions. Journal of Chemical Sciences. 135(3).
9.
Khosravi, Ayyoob, et al.. (2023). Impact of umbelliprenin-containing niosome nanoparticles on VEGF-A and CTGF genes expression in retinal pigment epithelium cells. International Journal of Ophthalmology. 17(1). 7–15. 3 indexed citations
10.
Rashidi, Mohsen, et al.. (2023). The effect of tetrahydrocannabinol:cannabidiol oromucosal spray on cognition: a systematic review. European Journal of Clinical Pharmacology. 79(3). 371–381. 4 indexed citations
11.
Hashemi, Mehrdad, Maryam Bagheri, Mitra Behroozaghdam, et al.. (2023). Versatile function of AMPK signaling in osteosarcoma: An old player with new emerging carcinogenic functions. Pathology - Research and Practice. 251. 154849–154849. 3 indexed citations
12.
Nikfar, Banafsheh, et al.. (2023). Hesperidin suppressed metastasis, angiogenesis and tumour growth in Balb/c mice model of breast cancer. Journal of Cellular and Molecular Medicine. 27(18). 2756–2769. 15 indexed citations
13.
Sadrkhanloo, Mehrdokht, Mahshid Deldar Abad Paskeh, Mehrdad Hashemi, et al.. (2023). STAT3 signaling in prostate cancer progression and therapy resistance: An oncogenic pathway with diverse functions. Biomedicine & Pharmacotherapy. 158. 114168–114168. 35 indexed citations
14.
Rashidi, Mohsen, Zhaleh Mohsenifar, Fariborz Faeghi, et al.. (2023). Examining the effect of Helicobacter pylori cagPAI variety on gene expression pattern related to gastric cancer. Hormone Molecular Biology and Clinical Investigation. 44(3). 251–258.
15.
Behroozaghdam, Mitra, Amirhossein Zabolian, Mehrdad Hashemi, et al.. (2022). Resveratrol in breast cancer treatment: from cellular effects to molecular mechanisms of action. Cellular and Molecular Life Sciences. 79(11). 539–539. 40 indexed citations
16.
Amani, Davar, et al.. (2021). Psoralidin exerts anti-tumor, anti-angiogenic, and immunostimulatory activities in 4T1 tumor‐bearing balb/c mice. Hormone Molecular Biology and Clinical Investigation. 43(1). 71–79. 15 indexed citations
17.
Amani, Davar, et al.. (2021). Antitumor effects of Auraptene in 4T1 tumor‐bearing Balb/c mice. Hormone Molecular Biology and Clinical Investigation. 42(3). 245–252. 6 indexed citations
18.
Amirmahani, Najmeh, Mohsen Rashidi, & Nosrat O. Mahmoodi. (2020). Synthetic application of gold complexes on magnetic supports. Applied Organometallic Chemistry. 34(5). 16 indexed citations
19.
Tavasolian, Fataneh, Ahmad Zavaran Hosseini, Mohsen Rashidi, et al.. (2020). The Impact of Immune Cell-derived Exosomes on Immune Response Initiation and Immune System Function. Current Pharmaceutical Design. 27(2). 197–205. 50 indexed citations
20.
Rashidi, Mohsen, Ahad Khalilnezhad, Davar Amani, et al.. (2018). Umbelliprenin shows antitumor, antiangiogenesis, antimetastatic, anti‐inflammatory, and immunostimulatory activities in 4T1 tumor‐bearing Balb/c mice. Journal of Cellular Physiology. 233(11). 8908–8918. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026